Glycogen storage disease type III in Israel: Presentation and long Term Outcome

Pediatric Endocrinology Reviews

Volumn 11, Issue 3, 2014, Pages 318-323

  Hershkovitz, Eli ^a   Forschner, Itay ^a   Mandel, Hanna ^b   Spiegel, Ronen ^c,d   Lerman Sagie, Tally ^e   Anikster, Yair ^f   Zeharia, A ^b   Moses, Shimon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MEYER CHILDREN S HOSPITAL   (Israel)

^c HAEMEK MEDICAL CENTER   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

^f SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Debranching; Glycogen; GSD III; Metabolism

Indexed keywords

ACUTE KIDNEY FAILURE; ARAB; ARTICLE; BLOOD BIOCHEMISTRY; CLINICAL FEATURE; DIABETES MELLITUS; DIET THERAPY; DISEASE COURSE; EUROPEAN; FAMILY STUDY; FOLLOW UP; GLYCOGEN STORAGE DISEASE TYPE 3; GROWTH ACCELERATION; GROWTH DISORDER; HEPATOMEGALY; HUMAN; HYPOGLYCEMIA; ISRAEL; LONG TERM CARE; MOLECULAR BIOLOGY; MUSCLE HYPOTONIA; MUSLIM; MYOPATHY; NORTH AFRICAN; OSTEOPOROSIS; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PHYSICAL DISEASE BY BODY FUNCTION; SOCIAL PSYCHOLOGY; ADOLESCENT; ADULT; AFRICA; CASE REPORT; CHILD; DIET RESTRICTION; ETHNOLOGY; EUROPE; FEMALE; GENETICS; HEART DISEASE; JEW; MALE; MUSCLE DISEASE; MUTATION; PRESCHOOL CHILD; RELIGION; REVIEW;

ADOLESCENT; ADULT; AFRICA, NORTHERN; ARABS; CHILD; CHILD, PRESCHOOL; EUROPE; FASTING; FEMALE; GLYCOGEN STORAGE DISEASE TYPE III; GROWTH DISORDERS; HEART DISEASES; HEPATOMEGALY; HUMANS; HYPOGLYCEMIA; ISLAM; ISRAEL; JEWS; MALE; MUSCULAR DISEASES; MUTATION;

EID: 84899535561     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocr Metab Disord. 2003; 4:95-102
2. Levin S, Moses SW, Chayoth R., Steinitz K. Glycogen storage disease in Israel, A clinical, biochemical and genetic study. Isr J Med Sci 1967; 3:397-410, 1967
3. Moses SW, Levin S, Chayoth R. Type III glycogen storage disease. J Pediatrics 1968; 72:297
4. Moses SW, Gadoth N, Ben David E., Slonim A, Wanderman KL. Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand 1986; 7:289-296
5. Moses SW, Wanderman KL, Myroz A, Frydman M, Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 1989; 148:764-766
6. Slonim AE, Coleman R, Moses SW, Myopathy and growth failure in debrancher enzyme deficiency: improvement with high protein nocturnal therapy. J Pediatr 1984; 105:905-911
7. Mishori-Dery A, Bashan N, Moses S, Hershkovitz E, Bao Y, Chen YT, Parvari R. RFLPs for linkage analysis in families with glycogen storage disease type III. J Inherit Metab Dis. 1995; 18:207-210
8. Parvarí R, Moses S, Shen J, Hershkovitz E, Lerner A, Chen YT. A single base deletion in the 3'-coding region of glycogen debranching enzyme in glycogen storage disease type IIIa in a population of North African Jewish Patients. Eur J Hum Genet 1997; 5:266-270
9. Parvari R, Shen J, Hershkovitz E, Chen YT, Moses SW. Two new mutations in the 3'-coding region of the glycogen debranching enzyme in a glycogen storage type IIIa Ashkenazi Jewish patient. J Inherit Metab Dis 1998; 21:141-148
10. Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D, Chen YT, Kishnani PS. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol 2007; 46:492-498
11. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24:276-279
12. Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, Emond J, Haagsma EB, Hug G, Lachaux A, Smit GP, Chen YT. liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999; 158(suppt 2):S43-S48
13. Siciliano M, De Candia E, Ballarin S, Vecchio FM, Servidei S, Annese R, Landolfi R, Rossi L. Hepatocellular carcinomacomplicating liver cirrhosis in type IIIa glycogen storage disease. J Clin Gastroenterol 2000; 31:80-82
14. Cosme A, Montalvo I, Sánchez J, Ojeda E, Torrado J, Zapata E, Bujanda L, Gutiérrez A, Arenas I. Type III glycogen storage disease associated with hepatocellular carcinoma. Gastroenterol Hepatol 2005; 28:622-625
15. Vertilus SM, Austin SL, Foster KS, Boyette KE, Bali DS, Li JS, Kishnani PS, Wechsler SB, Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time. Genet Med. 2010; 12:413-423
16. Ogimoto A, Okubo M, Okayama H, Shin YS, Endo Y, Ebara T, Inoue K, Ohtsuka T, Tahara H, Murase T, Higaki J. A Japanese patient with cardiomyopathy caused by a novel mutation R285X in the AGL gene. Circ J 2007; 71:1653-1656
17. Tada H, Kurita T, Ohe T, Shimomura K, Ishihara T, Yamada Y, Osawa N. Glycogen storage disease type III associated with ventricular tachycardia. Am Heart J 1995; 130:911-912
18. Carvalho JS, Matthew EE, Leonard JV, Deanfield J. Cardiomyopathy of glycogen storage disease type III. Heart Vessels 1993; 8:155-159
19. Cochrane AB, Fedson SE, Cronin II DC Nesiritide as bridge to multi-organ transplantation: a case report. Transplant Proc 2007; 39:308-331
20. Miller CG, Alleyne GA, Brooks SEH Gross cardiac involvement in Glycogen Storage Disease type III. Br Heart J 1972; 34:862-864
21. Shen J, Bao Y, Chen YT. A nonsense mutation due to a single base insertion in the 3--coding region of the glycogen debranching enzyme gene associated with a severe phenotype in a patient with Glycogen Storage Disease Types IIIa. Hum Mutat 1997; 9:37-40
22. Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF Jr, Ferreira P, Haworth JC, Herman GE, Issenman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfsdorf JI. Glycogen storage disease in adults. Ann Intern Med 1994; 120:218-226
23. Smit GP, Fernandes J, Leonard JV, Matthews EE, Moses SW, Odievre M, Ullrich K. The long-term outcome of patients with glycogen storage diseases. J Inherit Metab Dis 1990; 13:411-418
24. Hershkovitz E, Donald A, Mullen M, Lee PJ, Leonard JV. Blood lipids and endothelial function in glycogen storage disease type III. J Inherit Metab Dis 1999; 22:891-898
25. Slonim AE, Coleman RA, Moses WS. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr 1984; 105:906-911
26. Fernandes J, Leonard JV, Moses SW, Odièvre M, di Rocco M, Schaub J, Smit GP, Ullrich K, Durand P. Glycogen storage disease: recommendations for treatment. Eur J Pediatr 1988; 147:226-228
27. Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, Chung WK, Desai DM, El-Gharbawy A, Haller R, Smit GP, Smith AD, Hobson-Webb LD, Wechsler SB, Weinstein DA, Watson MS; Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010; 12:446-463
28. Dagli AI, Zori RT, McCune H, Ivsic T, Maisenbacher MK, Weinstein DA. Reversal of glycogen storage disease type llla-related cardiomyopathy with modification of diet. J Inherit Metab Dis 2009; 32 suppl 1:s103-106